SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-058671
Filing Date
2021-11-12
Accepted
2021-11-12 16:06:08
Documents
52
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_helixacq.htm   iXBRL 10-Q 459679
2 CERTIFICATION f10q0921ex31-1_helixacq.htm EX-31.1 13589
3 CERTIFICATION f10q0921ex31-2_helixacq.htm EX-31.2 12776
4 CERTIFICATION f10q0921ex32-1_helixacq.htm EX-32.1 4886
5 CERTIFICATION f10q0921ex32-2_helixacq.htm EX-32.2 4922
  Complete submission text file 0001213900-21-058671.txt   2724119

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hlxa-20210930.xsd EX-101.SCH 34422
7 XBRL CALCULATION FILE hlxa-20210930_cal.xml EX-101.CAL 14079
8 XBRL DEFINITION FILE hlxa-20210930_def.xml EX-101.DEF 151204
9 XBRL LABEL FILE hlxa-20210930_lab.xml EX-101.LAB 253774
10 XBRL PRESENTATION FILE hlxa-20210930_pre.xml EX-101.PRE 155811
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_helixacq_htm.xml XML 270744
Mailing Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116
Business Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116 857 702 0370
Helix Acquisition Corp (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39630 | Film No.: 211403396
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences